After three months of decline, French health care spending rose 0.1% in August this year compared with the previous month, according to the major health fund, the CNAMTS. The rise reflects higher payments to hospitals and out-patient treatment.
Spending reached 30.9 billion French francs ($6 billion) in August and 266 billion francs ($51.65 billion) in the first eight months of 1994.
Spending on private clinics continued to fall, but reimbursements in the general medical practice sector rose slightly, with spending on prescription medicines increasing by 0.2%. In the first half of this year, industry sales on the pharmaceutical market dipped 1%.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze